TABLE 4.
Conditions under which Teg41 expression is altered
| Expt | Conditions | Fold change | Expression value 1a |
Expression value 2a |
|---|---|---|---|---|
| 001.6 | UAMS-1 anaerobic 240 min vs nos KO 240 min | 3.7 | 0.47 | 1.74 |
| 001.12 | UAMS-1 anaerobic 0 min vs UAMS-1 anaerobic 120 min | 3.86 | 77.38 | 299.04 |
| 001.13 | UAMS-1 anaerobic 0 min vs UAMS-1 anaerobic 240 min | 25.71 | 6.82 | 175.42 |
| 002.3 | UAMS-1 ES vs UAMS-1 LE | 5.5 | 299.73 | 1,648.35 |
| 003.1 | Newman vs sulfide treated | 4.51 | 566.14 | 125.58 |
| 003.3 | Newman vs nitroxyl treated | 3.02 | 371.41 | 123.06 |
| 003.4 | Newman vs calprotectin treated | 3.61 | 211.92 | 765.35 |
| 005.4 | JE2 vs patient S nasal | 3.07 | 19.53 | 6.36 |
| 007.2 | HG003 vs rsaE plasmid complementation uninduced | 3.57 | 256.33 | 916.27 |
| 007.4 | rsaE mutant vs rsaE plasmid complementation uninduced | 3.24 | 255.62 | 828.92 |
| 014.1 | IPLA 1 biofilm vs treated with phage phiIPLA-RODI | 4.94 | 48.48 | 9.81 |
| 017.1 | PR01 vs RNase Y deletion | 13.65 | 73.12 | 997.88 |
| 018.1 | MRSA BD02-25 vs delta rsp | 8.75 | 9.95 | 87.05 |
a
Expression values are expressed in RPKM. Expression value 1 and expression value 2 represent the expression values of Teg41 under the two conditions tested. For details of each specific condition, see Supplemental Data Set S2.